Vedolizumab: What It Is, How It Works, and What You Need to Know

When you have vedolizumab, a biologic medication used to treat moderate to severe inflammatory bowel disease. It's also known as Entyvio, and unlike older drugs that weaken your whole immune system, it only blocks inflammation in your gut. This makes it a smarter choice for people who’ve tried other treatments but still struggle with flare-ups.

Vedolizumab works by stopping specific white blood cells from entering the lining of your intestines. These cells are what cause the swelling, pain, and diarrhea in conditions like Crohn's disease and a chronic condition causing inflammation anywhere in the digestive tract and ulcerative colitis, a disease that affects only the colon and rectum with continuous inflammation and ulcers. It doesn’t touch your lungs, skin, or joints—just your gut. That’s why side effects like infections or liver issues are less common than with other biologics.

People often turn to vedolizumab after steroids or TNF blockers like Humira or Remicade didn’t work—or caused bad side effects. Studies show about half of users see real improvement in symptoms within 6 weeks, and many stay in remission for over a year. It’s given as an IV infusion every 8 weeks after an initial loading dose, so you don’t need to inject yourself daily. That’s a big plus for folks who hate needles or can’t manage daily meds.

It’s not a cure, but it can change how you live. Many users report being able to eat without fear, go back to work, or play with their kids again. If you’re tired of constant bathroom trips, cramps, or feeling like your body’s turned against you, vedolizumab might be the middle ground you’ve been looking for—strong enough to help, but targeted enough to keep your whole system safe.

Below, you’ll find real comparisons and patient-focused guides on how vedolizumab stacks up against other treatments, what to expect during infusion, how to handle side effects, and when it’s better to switch to something else. These aren’t generic brochures—they’re practical insights from people who’ve been there.

20 November 2025 IBD Biologics Explained: Anti-TNF, Anti-Integrin, and IL-12/23 Inhibitors
IBD Biologics Explained: Anti-TNF, Anti-Integrin, and IL-12/23 Inhibitors

IBD biologics like anti-TNF, anti-integrin, and IL-12/23 inhibitors offer targeted treatment for Crohn's and ulcerative colitis. Learn how they work, compare their effectiveness, side effects, costs, and what's new in 2025.